酸酸酶和动脉硬化之间的积极关联:一个横截面研究
Yaqing Zhou1, Chen Chen2, Long Bai3
1Department of Physical Examination Center, The Second Hospital of Hebei Medical University, Shijiazhuang.
Journal of cardiovascular medicine (Hagerstown, Md.)
|August 22, 2023
概括
血清性酸酶 (ALP) 与早期动脉硬化有积极的联系,风险停滞在135U/l以上. 这种关联在糖尿病患者中没有显著意义.
科学领域:
- 心血管健康 心血管健康
- 生物化学 生化学
- 血管生物学 血管生物学
背景情况:
- 血清性酸酶 (ALP) 与心血管事件和脑动脉样硬化有关.
- ALP与早期动脉样硬化发展之间的特定关系需要进一步研究.
研究的目的:
- 为了检查血清ALP水平和早期动脉样硬化之间的关联.
- 为了评估早期动脉样硬化,使用手脚脉冲波速度 (Ba-PWV).
主要方法:
- 对5011名接受健康检查的参与者的回顾性分析.
- 使用回归分析,具有平滑函数的通用添加模型 (GAM),值效应分析和子组分析.
- 从2012年到2017年,测量了参与者的血清ALP和Ba-PWV.
主要成果:
- 在血清ALP和动脉硬化之间发现了显著的积极关联 (OR=1.008,P<0.001).
- 观察到一个两阶段的关联,和效应超过135U/l.
- 在糖尿病患者中没有明显的积极关联 (OR=0.996,P=0.690).
结论:
- 血清ALP水平与早期动脉样硬化有关,在135U/l以上水平时表现出和效应.
- 在糖尿病患者中,ALP和动脉硬化之间的联系尚不清楚.
- 脚脉冲波速度 (Ba-PWV) 在两组中都与动脉样硬化有正相关.
相关概念视频
Peripheral Artery Disease I: Introduction
9
Peripheral artery disease (PAD) predominantly results from atherosclerosis, which involves the accumulation of fatty deposits, or plaques, within the walls of arteries. This causes them to narrow and harden, significantly reducing blood flow. PAD predominantly affects the legs but also impacts other areas, such as the arms, thereby impairing overall circulation and organ function.Etiology of PAD:The principal cause of PAD is atherosclerosis, which results from fatty deposits inside the arterial...
9
Atherosclerosis I: Introduction
10
Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
10
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests
13
Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
13
Atherosclerosis III: Management
12
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
12
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation
17
Clinical manifestationsPeripheral Arterial Disease (PAD) manifests through a range of symptoms, from the characteristic intermittent claudication to atypical presentations and severe complications in advanced stages. Intermittent claudication, a hallmark symptom of PAD, presents as exercise-induced muscle pain that typically resolves within minutes of rest. This pain is reproducible and stems from inadequate blood flow, leading to the accumulation of lactic acid produced during anaerobic...
17
Coronary Artery Disease I: Introduction
20
Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
20


